NOVO HOLDINGS A/S

13F Portfolio Filings

Most recent 13F
Q2 2026
13D/G filings
13D on 4 securities, 13G on 8 securities
Location
Hellerup, Denmark
CIK
0001388325
Alternate names
Novo A/S
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 25 1,722,216 EWTX, ASML, COAG, BN 13F-HR 8/14/2026 000138832526000042
Q1 2026 22 1,234,214 EWTX, BN, ASML, MIRM 13F-HR 5/15/2026 000138832526000026
Q4 2025 24 1,287,677 BN, EWTX, ASML, MIRM 13F-HR 2/17/2026 000138832526000007
Q3 2025 27 1,551,582 VTI, BN, ASML, MIRM 13F-HR 11/14/2025 000138832525000025
Q2 2025 29 1,416,573 VTI, BN, ASML, CRM 13F-HR 8/14/2025 000141588925021889
Q1 2025 31 1,314,623 VTI, BN, EWTX, ASML 13F-HR 5/15/2025 000095012325005753
Q4 2024 34 1,651,736 VTI, BN, TEM, EWTX 13F-HR 2/14/2025 000095012325002801
Q3 2024 37 2,013,442 VTI, TEM, BN, EWTX 13F-HR 10/24/2024 000095012324009887
Q2 2024 38 1,854,897 VTI, BN, TEM, ASML RESTATEMENT 8/20/2024 000095012324008900
Q1 2024 35 1,449,667 ASML, BN, CRM, EPC 13F-HR 5/15/2024 000095012324005208
Q4 2023 36 1,619,344 BN, ASML, CRM, SPRO 13F-HR 2/14/2024 000095012324002161
Q3 2023 40 1,353,229 BN, ASML, CRM, CORT 13F-HR 11/14/2023 000095012323010600
Q2 2023 41 1,294,170 ASML, CRM, LNZA, CORT 13F-HR 8/14/2023 000095012323007714
Q1 2023 47 1,515,634 ASML, CRM, CYTT, BAM 13F-HR 5/15/2023 000095012323005002
Q4 2022 48 1,601,649 SYK, ASML, STE, CRM 13F-HR 2/14/2023 000095012323002359
Q3 2022 52 2,097,264 VTI, SYK, CTLT, BAM 13F-HR 11/14/2022 000095012322011721
Q2 2022 54 2,030,708 VTI, CTLT, SYK, BSX 13F-HR 8/15/2022 000095012322009223
Q1 2022 51 1,895,744 VTI, BAM, BSX, ASML RESTATEMENT 5/27/2022 000095012322006736
Q4 2021 48 2,111,971 VTI, EXAI, BAM, AAPL 13F-HR 2/14/2022 000095012322002394
Q3 2021 49 1,933,270 VTI, BAM, BSX, AAPL 13F-HR 11/15/2021 000095012321015112
Q2 2021 54 2,254,350 VTI, BAM, MORF, AAPL 13F-HR 8/16/2021 000095012321011090
Q1 2021 51 2,421,558 VTI, EWTX, MORF, BOLT 13F-HR 5/17/2021 000095012321006729
Q4 2020 45 2,332,562 VTI, NKTX, INGN, AAPL 13F-HR 2/16/2021 000095012321002364
Q3 2020 42 2,014,483 VTI, AAPL, CTLT, HRMY 13F-HR 11/16/2020 000095012320011935
Q2 2020 35 1,549,081 VTI, AAPL, INGN, CABO 13F-HR 8/14/2020 000095012320008748
Q1 2020 30 1,498,340 VTI, INGN, CABO, AAPL 13F-HR 5/15/2020 000095012320005049
Q4 2019 29 1,552,731 VTI, INGN, CABO, AAPL 13F-HR 2/14/2020 000095012320002402
Q3 2019 29 583,699 INGN, AAPL, CABO, MIST 13F-HR 11/14/2019 000095012319011293
Q2 2019 29 713,755 INGN, MIST, AAPL, CABO 13F-HR 8/14/2019 000095012319008284
Q1 2019 22 675,969 INGN, GKOS, CABO, KIDS 13F-HR 5/15/2019 000095012319005344
Q4 2018 23 710,313 INGN, GKOS, SPNE, KIDS 13F-HR 2/14/2019 000095012319002137
Q3 2018 1 3,766 C NEW HOLDINGS 2/6/2019 000095012319000714
Q3 2018 22 1,255,861 INGN, GKOS, CRVS, XLRN 13F-HR 11/14/2018 000095012318011813
Q2 2018 1 3,513 C NEW HOLDINGS 2/6/2019 000095012319000712
Q2 2018 18 991,060 INGN, XLRN, CRVS, MRUS 13F-HR 8/14/2018 000095012318008820
Q1 2018 17 797,426 INGN, XLRN, MNLO, CRVS 13F-HR 5/15/2018 000095012318005553
Q4 2017 14 713,357 INGN, XLRN, DERM, CRVS 13F-HR 2/14/2018 000095012318002147
Q3 2017 17 768,329 INGN, XLRN, DERM, CRVS 13F-HR 11/14/2017 000095012317010699
Q2 2017 21 835,774 INGN, ANAB, XLRN, SPNC 13F-HR 8/14/2017 000095012317007698
Q1 2017 22 939,094 INGN, ANAB, RETA, IRTC 13F-HR 5/15/2017 000095012317005095
Q4 2016 22 1,050,041 INGN, VTI, CLCD, VGK 13F-HR 2/14/2017 000095012317002225
Q3 2016 17 1,125,983 VTI, INGN, OPHT, CLCD 13F-HR 11/14/2016 000095012316022226
Q2 2016 18 952,621 VTI, OPHT, INGN, VGK 13F-HR 8/15/2016 000095012316019962
Q1 2016 17 912,485 VTI, OPHT, INGN, VGK 13F-HR 5/16/2016 000095012316017459
Q4 2015 14 1,040,415 OPHT, VTI, INGN, VGK 13F-HR 2/16/2016 000095012316014860
Q3 2015 19 967,913 VTI, OPHT, INGN, VGK 13F-HR 11/16/2015 000095012315012026
Q2 2015 19 1,390,516 VTI, OPHT, INGN, WMGIZ 13F-HR 8/14/2015 000095012315009039
Q1 2015 15 1,175,668 VTI, OPHT, VGK, INGN 13F-HR 5/15/2015 000095012315006094
Q4 2014 15 1,236,066 VTI, OPHT, INGN, VGK 13F-HR 2/17/2015 000095012315002217
Q3 2014 13 1,025,645 VTI, OPHT, VGK, INGN 13F-HR 11/14/2014 000095012314011904
Q2 2014 10 1,011,197 VTI, OPHT, VGK, INGN NEW HOLDINGS 11/14/2014 000095012314011903
Q2 2014 8 986,350 VTI, OPHT, VGK, INGN 13F-HR 8/14/2014 000110465914060605
Q1 2014 8 810,998 VTI, OPHT, VGK, INGN NEW HOLDINGS 11/14/2014 000095012314011901
Q1 2014 6 791,333 VTI, OPHT, VGK, INGN 13F-HR 8/14/2014 000110465914060604
Q4 2013 7 680,963 VTI, OPHT, VGK, WMGI NEW HOLDINGS 11/14/2014 000095012314011899
Q4 2013 5 659,209 VTI, OPHT, VGK, TETRAPHASE PHARMACEUTICALS INC 13F-HR 8/14/2014 000110465914060602
Q3 2013 5 403,786 VTI, VGK, WMGI, PTCT 13F-HR 11/14/2014 000095012314011896
Q2 2013 4 597,040 VTI, VGK, WMGI, WMGIZ 13F-HR 11/14/2014 000095012314011895
Q1 2013 4 589,855 VTI, VGK, WMGI, WMGIZ 13F-HR 11/14/2014 000095012314011894
Q4 2012 3 549,815 VTI, VGK, BIOMIMETIC THERAPEUTICS INC 13F-HR 11/14/2014 000095012314011892
Q3 2012 3 522,173 VTI, VGK, BIOMIMETIC THERAPEUTICS INC 13F-HR 11/14/2014 000095012314011891
Q2 2012 3 488,213 VTI, VGK, BIOMIMETIC THERAPEUTICS INC 13F-HR 11/14/2014 000095012314011890
Q1 2012 3 511,754 VTI, VGK, BIOMIMETIC THERAPEUTICS INC 13F-HR 11/14/2014 000095012314011888
Q4 2011 3 460,144 VTI, VGK, BIOMIMETIC THERAPEUTICS INC 13F-HR 11/14/2014 000095012314011885
Q3 2011 4 437,206 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011884
Q2 2011 4 403,094 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011881
Q1 2011 4 438,337 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011880
Q4 2010 4 416,500 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011879
Q3 2010 4 344,712 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011876
Q2 2010 4 272,784 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011875
Q1 2010 4 315,867 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011872
Q4 2009 4 281,465 VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ 13F-HR 11/14/2014 000095012314011863
Additional filings from Novo Holdings A/S that have since been restated

13D and 13G Filings

All 13D and 13G filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Maplight Therapeutics, Inc. 13D/A
MPLT · 56565P103
 4.9% 7/31/2026
Event 7/30/2026
Edgewise Therapeutics, Inc. 13D/A
EWTX · 28036F105
 4.9% 4/27/2026
Event 4/23/2026
IO Biotech, Inc. 13D/A
IOBTQ · 449778109
 3.3% 1/23/2026
Event 1/21/2026
Galecto, Inc. 13D/A
GLTO · 36322Q107
 0% 10/9/2025
Event 10/7/2025

8 other securities where the latest filing is a 13G, the newest filed 8/14/2026. View all